REHOVOT, Israel, Dec. 17, 2024 /PRNewswire/ -- Amai Proteins, a scale-up designer of novel proteins that answer the needs of consumers and industry, has succesfullly completed world's first double-blind, random clinical trial on the effects of their proprietary hyper-sweet protein, sweelin®, on bloo...
SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder platform designed to selectively target tumor cells SK Biopharmaceuticals eyes innovative small protein-based radiopharmaceuticals on safety and effic...
Acknowledged for strong environmental, social, and governance (ESG) performance and continued commitment to sustainability through net-zero initiatives and responsible value chain management INCHEON, South Korea, Dec. 17, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract ...
CUPERTINO, Calif., Dec. 17, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The trial showed a threefold increase in the objective...
If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important. NEW YORK, Dec. 17, 2024 /PRNewswire/ -- The following is being issued by Kroll Restructuring Administration LLC....
– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p
KOTA KINABALU, Malaysia, Dec. 16, 2024 /PRNewswire/ -- A groundbreaking new book by Professor Dr. Mike Chan, "STEM CELLS, PEPTIDES & IMMUNOTHERAPY: Handbook on Regenerative Medicine for Animals," introduces revolutionary stem cell therapies that promise to extend the health span and longevity of hor...
The acquisition strengthens Everise's position as a leading end-to-end healthcare experience provider PLANTATION, Fla., Dec. 16, 2024 /PRNewswire/ -- Everise, a global healthcare customer experience leader, today announced the successful completion of its acquisition of customer experience manageme...
CAMBRIDGE, Mass., Dec. 16, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), today announced a research collaboration and license agreement to discover next-generation T-cell engagers ("TCEs") with Candid Therapeutics, Inc...
SINGAPORE, Dec. 16, 2024 /PRNewswire/ -- Perennial Holdings Private Limited ("Perennial Holdings") is pleased to announce that Perennial General Hospital in Tianjin city ("Perennial General Hospital Tianjin"), China, has become the country's first wholly foreign-owned private tertiary general hospit...
